Burow Kristina

CIK 000156924819 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001569248

Recent Transactions

50 trades

Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−8,313,680→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−7,523,682→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Stock Option (right to buy)
2025-11-13−16,125→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−17,070,904→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−2,688→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−18,503,128→ 0 total
Award
Metsera, Inc.$MTSR
Restricted Stock Unit
2025-11-13+2,688→ 2,688 total
Disposition to Issuer
Metsera, Inc.$MTSR
Stock Option (right to buy)
2025-11-13−148,953→ 0 total
Purchase
Neumora Therapeutics, Inc.$NMRA
Common Stock
2025-10-27$2.61/sh+1,915,700→ 6,046,907 total
Purchase
Prime Medicine, Inc.$PRME
Common Stock
2025-08-01$3.30/sh+3,030,300→ 6,230,300 total
Award
Boundless Bio, Inc.$BOLD
Stock Option (right to buy)
2025-06-23+16,000→ 16,000 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2025-05-29$29.24/sh−1,000→ 25,471 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2025-05-29$29.83/sh−4,400→ 21,071 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+46,455→ 46,455 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+28,571→ 28,571 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−28,571→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+80,000→ 80,000 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−46,455→ 0 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-05-22+7,632→ 26,471 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2025-05-22+9,206→ 9,206 total
Award
Metsera, Inc.$MTSR
Stock Option (Right to Buy)
2025-05-20+16,125→ 16,125 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−28,571→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+28,571→ 28,571 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+46,455→ 46,455 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−46,455→ 0 total
Purchase
Metsera, Inc.$MTSR
Common Stock
2025-02-03$18.00/sh+789,998→ 8,313,680 total
Conversion
Metsera, Inc.$MTSR
Series Seed Preferred Stock
2025-02-03−19,933,333→ 0 total
Conversion
Metsera, Inc.$MTSR
Series B Convertible Preferred Stock
2025-02-03−2,678,571→ 0 total
Conversion
Metsera, Inc.$MTSR
Series A Convertible Preferred Stock
2025-02-03−15,000,000→ 0 total
Purchase
Metsera, Inc.$MTSR
Common Stock
2025-02-03$18.00/sh+1,432,224→ 18,503,128 total
Conversion
Metsera, Inc.$MTSR
Series A Convertible Preferred Stock
2025-02-03−15,000,000→ 0 total
Conversion
Metsera, Inc.$MTSR
Common Stock
2025-02-03+7,523,682→ 7,523,682 total
Conversion
Metsera, Inc.$MTSR
Series B Convertible Preferred Stock
2025-02-03−2,678,571→ 0 total
Conversion
Metsera, Inc.$MTSR
Common Stock
2025-02-03+16,006,949→ 17,070,904 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2024-06-27+18,000→ 18,000 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2024-06-27+13,500→ 18,839 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2024-06-13+28,571→ 28,571 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-06-13+20,100→ 47,717 total
Conversion
Rapport Therapeutics, Inc.$RAPP
Series A Preferred Stock
2024-06-10−20,000,000→ 0 total
Conversion
Rapport Therapeutics, Inc.$RAPP
Common Stock
2024-06-10+3,728,738→ 3,728,738 total
Conversion
Rapport Therapeutics, Inc.$RAPP
Series B Preferred Stock
2024-06-10−11,924,138→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total
Purchase
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02$16.00/sh+133,333→ 1,181,766 total
Purchase
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02$16.00/sh+66,667→ 683,759 total
Conversion
Boundless Bio, Inc.$BOLD
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+1,048,433→ 1,048,433 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+787,545→ 828,570 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+589,743→ 617,092 total

Companies

Recent Filings

Address

8725 WEST HIGGINS ROAD, SUITE 290

CHICAGO, IL, 60631

View on SEC.gov